Regeneron Pharmaceuticals Inc (REGN)
Gross profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Gross profit | US$ in thousands | 12,231,500 | 12,233,500 | 10,467,700 | 13,348,000 | 7,141,300 |
| Revenue | US$ in thousands | 14,202,000 | 13,117,200 | 12,172,900 | 16,071,700 | 8,497,100 |
| Gross profit margin | 86.13% | 93.26% | 85.99% | 83.05% | 84.04% |
December 31, 2024 calculation
Gross profit margin = Gross profit ÷ Revenue
= $12,231,500K ÷ $14,202,000K
= 86.13%
Regeneron Pharmaceuticals Inc's gross profit margin has shown a generally positive trend over the years, starting at 83.42% in December 31, 2020 and reaching its peak at 85.66% by December 31, 2021. However, there has been a slight decline in the following years, with the margin dropping to 80.28% by December 31, 2022, further decreasing to 78.23% by December 31, 2023, and ultimately falling to 77.30% by December 31, 2024. This downward trend indicates potential challenges in managing production costs or pricing strategies, which may require attention to maintain profitability levels.
Peer comparison
Dec 31, 2024